Zura Bio Limited Class A Ordinary Shares (US: ZURA) — Healthcare · Share Price, Chart & Market Data
About: Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.38 (-2.54%)
ZURAZura Bio Limited Class A Ordinary Shares
Loading watchlist status…
Trade ZURA now
Zura Bio Limited Class A Ordinary Shares share price
ZURA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:21 pm GMT+0
ZURA price performance
1.701%
5D
-9.275%
1M
-3.063%
YTD
281.56%
1Y
ZURA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:21 pm GMT+0
ZURA details
ZURA Market Signals